Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.
Incarceration
Opioid use disorder
Pre-exposure prophylaxis (PrEP)
Qualitative research
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
09
03
2019
revised:
23
08
2019
accepted:
27
08
2019
entrez:
22
9
2019
pubmed:
22
9
2019
medline:
5
9
2020
Statut:
ppublish
Résumé
People who are incarcerated are at increased risk for HIV (human immunodeficiency virus) acquisition upon release, and one possible intervention for prevention is the use of pre-exposure prophylaxis (PrEP) upon release. The present study assessed HIV risk perceptions as well as PrEP awareness and interest among 39 people who were incarcerated and enrolled in a structured Medication for Addiction Treatment (MAT) program at the Rhode Island Department of Corrections using semi-structured, qualitative interviews. Analysis was conducted using a generalized, inductive method in NVivo 12. While PrEP awareness was low across the study sample, some participants were interested in PrEP uptake or learning more about PrEP after they were provided with an overview of it. PrEP interest strongly related to current perceived HIV risk. Potential barriers included side effects, adherence, and reluctance to take medications in general. MAT programs for people who are criminal justice (CJ) involved may serve as useful linkage spaces to PrEP information, access, and retention.
Identifiants
pubmed: 31540614
pii: S0740-5472(19)30164-3
doi: 10.1016/j.jsat.2019.08.015
pmc: PMC10347805
mid: NIHMS1539483
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
73-78Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM125507
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA044443
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Top Antivir Med. 2016 Jul/Aug;24(2):90-92
pubmed: 27841978
J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):119-127
pubmed: 29084044
AIDS Behav. 2015 May;19(5):752-7
pubmed: 25086669
AIDS. 2017 Mar 13;31(5):731-734
pubmed: 28060019
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):250-258
pubmed: 28708811
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554-61
pubmed: 25564105
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
Curr HIV/AIDS Rep. 2018 Jun;15(3):266-275
pubmed: 29774442
AIDS Behav. 2014 Sep;18(9):1694-700
pubmed: 24752703
Drug Alcohol Depend. 2019 Feb 1;195:148-155
pubmed: 30639794
Front Public Health. 2018 Jul 13;6:195
pubmed: 30062091
Lancet. 2014 Feb 1;383(9915):399-400
pubmed: 24494225
PLoS One. 2018 Dec 7;13(12):e0205593
pubmed: 30532275
Arch Sex Behav. 2018 Oct;47(7):2109-2121
pubmed: 29327091
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1:S32-6
pubmed: 21045597
J Urban Health. 2011 Apr;88(2):365-75
pubmed: 21286825
J Clin Virol. 2016 Mar;76:8-13
pubmed: 26774543
AIDS Care. 2009 Feb;21(2):235-43
pubmed: 19229694
Lancet. 2008 Nov 15;372(9651):1733-45
pubmed: 18817968
J Offender Rehabil. 2018;57(8):525-537
pubmed: 31666789
AIDS Behav. 2016 Jul;20(7):1461-9
pubmed: 25835463
Harm Reduct J. 2017 Jun 29;14(1):40
pubmed: 28662716
Lancet. 2015 Jul 25;386(9991):350-9
pubmed: 26028120
Sci Transl Med. 2012 Sep 12;4(151):151ra125
pubmed: 22972843
N C Med J. 2016 Sep-Oct;77(5):359-64
pubmed: 27621350
PLoS One. 2009 Nov 11;4(11):e7558
pubmed: 19907649
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
J Subst Abuse Treat. 2013 Aug;45(2):222-6
pubmed: 23541303
Addiction. 2017 Apr;112(4):572-578
pubmed: 27273843
AIDS Behav. 2017 May;21(5):1299-1308
pubmed: 27990587
Drug Alcohol Depend. 2016 Jul 01;164:8-13
pubmed: 27177804
Lancet. 2013 Jun 15;381(9883):2083-90
pubmed: 23769234
N Engl J Med. 2012 Aug 2;367(5):399-410
pubmed: 22784037
AIDS Care. 2019 Mar;31(3):364-369
pubmed: 30227719
Adv Prev Med. 2013;2013:183187
pubmed: 23346410
Drug Alcohol Depend. 2019 Dec 1;205:107514
pubmed: 31614328
J Acquir Immune Defic Syndr. 2016 Nov 1;73(3):323-331
pubmed: 27763996
Curr HIV/AIDS Rep. 2018 Jun;15(3):255-258
pubmed: 29752698
Drug Alcohol Depend. 2014 Sep 1;142:33-40
pubmed: 24962326